Featured Articles

31. Think About The Big Picture! Delivering More Opportunities 9/27/2024

    Failing to recruit and retain patients results in 86% of all trials missing their deadlines and 30% of Phase III trials failing. Learn how focusing on patients and sites can drive results for trials.

32. Accelerating Timelines By Bringing Clinical Trials To Patients' Communities 9/27/2024

    Accelerating overall trial timelines is critical to minimizing the financial risk of a clinical trial, and a hybrid trial model could work to speed up your recruitment and improve retention.

33. How To Build A Hybrid Visit Strategy That Delivers High-Quality Results 7/11/2024

    In-home clinical trial visits yield major benefits for patients, including increased access and convenience. As a result, hybrid trials are helping developers increase enrollment, engagement, and retention.

34. The Role For Decentralization In Condensing Timelines 3/22/2024

    Discover how prioritizing patient-centricity and decentralization in clinical trials optimizes timelines and budgets, with expert insights into recruitment, attrition, and implementation strategies.

35. How To Realize The Value Of Patient-Centric Solutions 3/21/2024

    To realize the full value of patient-centric solutions sponsors, sites and patients all need to be continually integrated from concept to trial completion.

36. What Are Hybrid Trials Like For Patients? 2/21/2024

    When a patient has the choice to have a more convenient trial, recruitment and enrollment increase, and retention is improved. Learn how patient-centric trial delivery can keep patients engaged.

37. Protocol Designs That Maximize The Value Of Hybrid Clinical Trials 12/21/2023

    Sponsors can maximize the value of hybrid clinical trials by prioritizing patient experience in trial design, balancing technologies with in-home care, site visits, and more to achieve the right design.

38. What's Missing From Decentralized Trials? The Human Element 10/6/2023

    DCTs are complex, and disconnects between sites and solution providers are common. However, a dedicated site management team improves relationships between providers and sites to maximize DCTs’ value.

39. Decentralized Trials For Duchenne Muscular Dystrophy 8/24/2023

    Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.

40. Improving The Oncology Patient Experience In Clinical Trials 8/18/2023

    Due to the flexibility and reduced burdens that they offer, decentralized clinical trials have the potential to positively impact all stakeholders, most importantly, the patients.